Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
about
Remyelinating Pharmacotherapies in Multiple Sclerosis.Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.Upregulation of Myelin Gene Expression by a Physically-Modified Saline via Phosphatidylinositol 3-Kinase-Mediated Activation of CREB: Implications for Multiple Sclerosis.Are sigma receptor modulators a weapon against multiple sclerosis disease?p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.
P2860
Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Attempts to Overcome Remyelina ...... venues for Multiple Sclerosis.
@en
Attempts to Overcome Remyelina ...... venues for Multiple Sclerosis.
@nl
type
label
Attempts to Overcome Remyelina ...... venues for Multiple Sclerosis.
@en
Attempts to Overcome Remyelina ...... venues for Multiple Sclerosis.
@nl
prefLabel
Attempts to Overcome Remyelina ...... venues for Multiple Sclerosis.
@en
Attempts to Overcome Remyelina ...... venues for Multiple Sclerosis.
@nl
P2860
P1476
Attempts to Overcome Remyelina ...... Avenues for Multiple Sclerosis
@en
P2093
Mahsa Motavaf
Majid Sadeghizadeh
P2860
P2888
P304
P356
10.1007/S10571-017-0472-6
P577
2017-02-21T00:00:00Z